Big Pharma expanded in emerging markets by 6.1% last quarter, but GSK and Eli Lilly didn't reap as much growth as their peers
It’s dance time for Astellas’ new ad campaign. The company has partnered up with the ABC show “Dancing with the Stars” for its newest Myrbetriq push.
The forces of competition are mounting against Humira, the world’s best-selling drug at $16 billion in global sales, with approval of a second biosimilar in…
GSK has formed an alliance with China’s e-commerce giant Alibaba to help promote HPV vaccine Cervarix.
Remember Doan’s for back pain? It's back, thanks to Dr. Reddy’s Laboratories, which is breathing new marketing life into a handful of older brands.
Daiichi Sankyo, already losing sales to generics of blockbuster Benicar, has agreed to pay $300 million to settle litigation tied to the drug.
A second Remicade biosimilar hit the U.S. market to take a larger slash at pricing.
After an average 44% price cuts, Chinese government will add some blockbuster foreign meds like Celgene's Revlimid to its national insurance scheme.
With a patent loss looming, Takeda filed a citizen petition pushing the FDA to knock back generic Velcade competition.
The European Medicines Agency today recommended approval of Imraldi, a Humira biosimilar from Samsung and Biogen.